SCHEDULE: Nantahala Capital Discloses 5.68% Stake in Rallybio

Nantahala Capital Management, LLC and its principals have reported a 5.68% beneficial ownership stake in Rallybio Corporation.

Summary

• Nantahala Capital Management, LLC, along with managing members Wilmot B. Harkey and Daniel Mack, filed a Schedule 13G reporting beneficial ownership of 300,635 shares of Rallybio Corporation common stock.
• The reported stake represents 5.68% of the company's outstanding common stock as of March 31, 2026.
• The reporting persons hold shared voting and dispositive power over the entire 300,635 share position.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral regulatory event, reflecting standard institutional portfolio management rather than a strategic shift or operational update.

Positives

• Institutional investment firm demonstrates confidence in Rallybio by maintaining a position exceeding the 5% threshold.

Negatives

• None identified; this is a standard regulatory disclosure of beneficial ownership.

Risks

• The filing notes that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Future Outlook

The filing does not provide forward-looking guidance, as it is a standard disclosure of ownership status.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures for institutional investors. An increase in institutional ownership in a biotech firm like Rallybio often signals long-term interest from specialized healthcare investment funds.

Comparison to Industry Standards

• The filing follows standard SEC regulatory requirements for institutional investors holding more than 5% of a public company's equity.
• The reporting structure is consistent with typical disclosures by investment advisers and their managing members.

Stakeholder Impact

• Shareholders may view the presence of an institutional investor with a 5.68% stake as a sign of market validation.

Next Steps

• The reporting persons are required to file amendments to this statement if there are any material changes in the percentage of shares owned.

Key Dates

Keywords

Rallybio, Nantahala Capital, Schedule 13G, Beneficial Ownership, Biotech, Institutional Investor